Focused Wealth Management, Inc Regeneron Pharmaceuticals, Inc. Transaction History

Focused Wealth Management, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$902.69 - $993.35 $91,171 - $100,328	101 Added 918.18%	112 $107,000
Q4 2023 Jan 10, 2024	SELL	$775.18 - $881.7 $11,627 - $13,225	-15 Reduced 57.69%	11 $9,000
Q3 2023 Nov 01, 2023	SELL	$692.45 - $844.37 $29,775 - $36,307	-43 Reduced 62.32%	26 $21,000
Q2 2022 Aug 04, 2022	BUY	$548.35 - $738.84 $8,225 - $11,082	15 Added 27.78%	69 $41,000
Q4 2020 Feb 03, 2021	BUY	$478.3 - $607.98 $21,523 - $27,359	45 Added 500.0%	54 $26,000
Q3 2020 Oct 19, 2020	SELL	$544.75 - $658.21 $81,712 - $98,731	-150 Reduced 94.34%	9 $5,000
Q2 2020 Jul 24, 2020	BUY	$493.32 - $643.92 $73,998 - $96,588	150 Added 1666.67%	159 $99,000
Q3 2019 Nov 06, 2019	SELL	$273.46 - $318.39 $32,815 - $38,206	-120 Reduced 93.02%	9 $2,000
Q2 2019 Jul 19, 2019	BUY	$299.6 - $414.82 $35,952 - $49,778	120 Added 1333.33%	129 $40,000
Q4 2018 Jan 30, 2019	SELL	$335.82 - $403.04 $708,244 - $850,011	-2,109 Reduced 99.58%	9 $3,000
Q3 2018 Nov 13, 2018	SELL	$351.14 - $408.51 $43,541 - $50,655	-124 Reduced 5.53%	2,118 $856,000
Q2 2018 Aug 15, 2018	BUY	$284.6 - $344.99 $638,073 - $773,467	2,242 New	2,242 $773,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Focused Wealth Management, Inc with notifications on news.